Silver Book Fact

If all untreated patients with Stage I or II hypertension had been treated and achieved normal blood pressures, there would have been 420,000 fewer hospital discharges in 2002 than actually occurred because of stroke and myocardial infarction.

Cutler D, Long G, Berndt E, Royer J, et al. The Value Of Antihypertensive Drugs: A perspective on medical innovation. Health Affairs. 2007; 26(1): 97-110

Reference

Title
The Value Of Antihypertensive Drugs: A perspective on medical innovation
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Cutler D, Long G, Berndt E, Royer J, et al.
Volume & Issue
Volume 26, Issue 1
Pages
97-110

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Treatment for hypertension using antihypertensive therapy has generated a benefit-to-cost ratio of at least 6:1.  
  • The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.  
  • There are currently 312 medicines in development for heart disease and stroke.  
  • Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.  
  • The greater use of medications and revascularization would provide approximately a 17% reduction in 2 year mortality combined.